{"id":"W2166246129","doi":"10.1158/1078-0432.ccr-04-0452","title":"Phase I Study of Docetaxel in Combination with the P-Glycoprotein Inhibitor, Zosuquidar, in Resistant Malignancies","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources","keywords":"Docetaxel; Pharmacokinetics; Medicine; Neutropenia; Pharmacology; Dosing; Toxicity; Chemotherapy; Internal medicine; Urology; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007313093,0.00109408,0.001829309,0.0003694859,0.0003587922,0.000689286,0.0007602561,0.0007009238,0.001631505],"category_scores_gemma":[0.0006886101,0.0005428463,0.0008966911,0.0004409474,0.0009096833,0.0004480992,0.0002003064,0.001945092,0.0003799731],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009801871,"about_ca_system_score_gemma":0.001599556,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001422078,"about_ca_topic_score_gemma":0.003670775,"domain_scores_codex":[0.9996748,0.0001340638,0.00001898203,0.00006059731,0.00004731464,0.00006434336],"domain_scores_gemma":[0.9995746,0.00006510883,0.0001095785,0.00004227982,0.00002485851,0.0001834813],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.421325,0.08304417,0.01582822,0.001773163,0.002040816,0.0008251835,0.0008305903,0.008704599,0.2971906,0.0005865194,0.004159904,0.1636913],"study_design_scores_gemma":[0.3566142,0.5964425,0.0187668,0.00005854608,0.0006238978,0.0009763712,0.00008615735,0.002212573,0.02016886,0.0001507411,0.003855265,0.00004410003],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955469,0.002021658,0.0004460072,0.000193927,0.00004802608,0.0008743404,0.0002686034,0.00004209617,0.000558355],"genre_scores_gemma":[0.994484,0.001752369,0.001154907,0.0001779562,0.00006302783,0.0006787006,0.0007187742,0.00001845623,0.000951784],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001829309,"threshold_uncertainty_score":0.007111788,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1295801785086009,"score_gpt":0.473648254050959,"score_spread":0.3440680755423581,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}